Clinical trial
A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
NCT00113542 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00113542 |
|---|---|
| Title | A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris |
| Official title | An Open Label Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris |
| Lead sponsor | University of Michigan, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Tetrathiomolybdate (TM) |
| Enrollment | 10 |
| Start date | Jun 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jun 9, 2005 |
| Last update posted | May 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: